Barinthus Biotherapeutics (BRNS) Asset Utilization Ratio (2021 - 2025)

Barinthus Biotherapeutics has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.14 in Q4 2025.

• For the quarter ending Q4 2025, Asset Utilization Ratio rose 68.31% year-over-year to 0.14; the trailing twelve-month figure through Dec 2025 stood at 0.14 (up 68.31% YoY), and the FY2024 full-year result was 0.08, up 2313.59% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.14, up from 0.13 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.16 in Q4 2022, with the low at 0.0 in Q4 2021.
• Historically, Asset Utilization Ratio has averaged 0.07 across 5 years, with a median of 0.05 in 2022.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio surged 16323.46% — and 2024, when it slumped 98.58%.
• Barinthus Biotherapeutics' Asset Utilization Ratio stood at 0.0 in 2021, then soared by 16323.46% to 0.16 in 2022, then slumped by 97.8% to 0.0 in 2023, then jumped by 2276.96% to 0.09 in 2024, then jumped by 68.31% to 0.14 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.14 (Q4 2025), 0.13 (Q3 2025), and 0.09 (Q4 2024), per Business Quant data.